We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PSG.F

Price
28.40
Stock movement down
-0.40 (-1.39%)
Company name
PharmaSGP Holding SE
Exchange
(F
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Markedsværdi
340.52M
Ent værdi
395.32M
Pris/omsætning
2.99
Pris/bog
9.22
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
18.11
Fremtidig P/E
12.03
PEG
-
EPS-vekst
-
1 års afkast
21.37%
3 års afkast
6.37%
5 års afkast
-1.93%
10 års afkast
-
Senest opdateret: 2025-06-22

UDBYTTE

PSG.F betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E18.11
Pris til OCF11.30
Pris til FCF11.91
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning2.99
Pris til egenkapital9.22
EV i forhold til salg3.47

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier11.99M
EPS (TTM)1.57
FCF pr. aktie (TTM)2.38

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)114.00M
Bruttofortjeneste (TTM)103.67M
Driftsindkomst (TTM)26.76M
Nettoindkomst (TTM)18.80M
EPS (TTM)1.57
EPS (1 år frem)2.36

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)90.94%
Driftsmargin (TTM)23.47%
Fortjenstmargin (TTM)16.49%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter37.77M
Nettotilgodehavender15.97M
Omsætningsaktiver i alt67.45M
Goodwill0.00
Immaterielle aktiver0.00
Ejendomme, anlæg og udstyr920.00K
Sum aktiver129.52M
Kreditor13.05M
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser29.78M
Sum gæld92.57M
Aktionærernes egenkapital36.95M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)30.14M
Investeringsudgifter (TTM)1.55M
Fri pengestrøm (TTM)28.59M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast50.88%
Afkast af aktiver14.51%
Afkast af investeret kapital50.88%
Kontant afkast af investeret kapital77.38%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning28.40
Daglig høj28.40
Daglig lav28.40
Daglig volumen0K
Højeste gennem alle tider33.80
1 års analytiker estimat38.75
Beta-0.10
EPS (TTM)1.57
Udbytte pr. aktie-
Ex-div dato27 Jun 2024
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
PSG.FS&P500
Nuværende prisfald fra top notering-15.98%-3.04%
Højeste prisfald-52.81%-56.47%
Højeste efterår dato5 May 20219 Mar 2009
Gennemsnitlig fald fra toppen-28.41%-11.04%
Gennemsnitlig tid til nyt højdepunkt1277 days12 days
Maks. tid til nyt højdepunkt1276 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
PSG.F (PharmaSGP Holding SE) company logo
Markedsværdi
340.52M
Markedsværdi kategori
Small-cap
Beskrivelse
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
Personale
89
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Germany
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
91.12% of the registered share capital was represented Minimum dividend of EUR 0.05 per dividend-bearing share resolved Management Board reports on successful operational development in 2024; forecast...
26. juni 2025
PharmaSGP Holding SE ( ETR:PSG ) is reducing its dividend from last year's comparable payment to €0.51 on the 1st of...
17. maj 2025
As Europe grapples with the ripple effects of unexpected U.S. trade tariffs, resulting in significant declines across major indices like the STOXX Europe 600, investors are searching for opportunities...
8. april 2025
As European markets navigate the challenges of new U.S. trade tariffs and fluctuating economic indicators, investors are keenly observing opportunities that may arise in the dividend stock segment. In...
2. april 2025
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
17. marts 2025
As global markets navigate a landscape marked by fluctuating corporate earnings and geopolitical tensions, small-cap stocks have shown resilience amidst volatility, with the S&P 600 providing a glimps...
4. februar 2025
As global markets experience a rebound, driven by easing inflation and robust bank earnings in the U.S., investors are increasingly optimistic about potential rate cuts later in the year. Amid this ba...
24. januar 2025
As global markets navigate a mixed landscape, with the S&P 500 closing out a strong year despite recent declines and economic indicators like the Chicago PMI signaling contraction, investors are incre...
6. januar 2025
As global markets navigate a landscape of rate cuts and economic adjustments, investors have seen mixed performances across major indices, with the Nasdaq hitting record highs while other indexes decl...
16. december 2024
The subdued stock price reaction suggests that PharmaSGP Holding SE's ( ETR:PSG ) strong earnings didn't offer any...
6. december 2024
Næste side